Track the Abacus Life, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 23 December 2024 (Cession). Among the most active insiders: Gusky Adam Samuel. All data is accessible without an account.
31
Insider Decl.
n/a
Thresholds
€349,941
7 ops.
Buy Volume
€21m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Abacus Life, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
48Σ signal
Buys €349,941€21m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,967 of 29,062 companies
28.9
score / 100
Value
23
Quality
35
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn88%
Net mgn-55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Abacus Life, Inc. es una empresa que cotiza en el mercado XNAS. Se especializa en soluciones financieras relacionadas con la gestión de activos e inversiones.